Stage IVC Squamous Cell Carcinoma of the Oropharynx Withdrawn Phase 1 Trials for DB00515 (Cisplatin)

IndicationStatusPhase
DBCOND0029839 (Stage IVC Squamous Cell Carcinoma of the Oropharynx)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01728480Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation TherapyTreatment